Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
Week 1 of the American Association for Cancer Research (AACR) Annual Meeting was held virtually from Apr 10 - 15. Leading experts in the field presented novel and evolving insights into the biology, diagnosis and treatment of hematological malignancies.
AACR 2021
#ASH23 a great opportunity to discuss with colleagues from #Armenia about the development of clinical research in hematology in Yerevan @NersesGH Prof. Y. Hakobyan #ArmenianHematologyAssociation
#ASH23 HOVON analysis of dynamic frailty in #MMsm - building on work by @HiraSMian @tanyawildes et al.
Some pts get less frail with myeloma treatment đź‘Ź
Also note that, of pts who become “frailer,” some of this is artifactual because IMWG model de facto penalizes older age.
Great chatting with @tarekmd91 (@IcahnMountSinai) who gave an overview of updates on the use of #CART in #MultipleMyeloma
@ASH_hematology #Myeloma #MMsm #HemOnc
#ASH23 | We spoke with @NersesGH from Yeolyan Hematology and Oncology Center on challenges that remain in the diagnosis and treatment of #BPDCN
@ASH_hematology #HemOnc
Head to poster number 1861 at #ASH23 at 5:30 pm to learn more!
@Daver_Leukemia
@doctorpemm
@DrHKantarjian
@MDAndersonNews
#leusm
#mpnsm
AACR 2021
Week 1 of the American Association for Cancer Research (AACR) Annual Meeting was held virtually from Apr 10 - 15. Leading experts in the field presented novel and evolving insights into the biology, diagnosis and treatment of hematological malignancies.
#ASH23 a great opportunity to discuss with colleagues from #Armenia about the development of clinical research in hematology in Yerevan @NersesGH Prof. Y. Hakobyan #ArmenianHematologyAssociation
#ASH23 HOVON analysis of dynamic frailty in #MMsm - building on work by @HiraSMian @tanyawildes et al.
Some pts get less frail with myeloma treatment đź‘Ź
Also note that, of pts who become “frailer,” some of this is artifactual because IMWG model de facto penalizes older age.
Great chatting with @tarekmd91 (@IcahnMountSinai) who gave an overview of updates on the use of #CART in #MultipleMyeloma
@ASH_hematology #Myeloma #MMsm #HemOnc
#ASH23 | We spoke with @NersesGH from Yeolyan Hematology and Oncology Center on challenges that remain in the diagnosis and treatment of #BPDCN
@ASH_hematology #HemOnc
Head to poster number 1861 at #ASH23 at 5:30 pm to learn more!
@Daver_Leukemia
@doctorpemm
@DrHKantarjian
@MDAndersonNews
#leusm
#mpnsm
